TANGO1 interacts with NRTN to promote hepatocellular carcinoma progression by regulating the PI3K/AKT/mTOR signaling

Jing Man1, Wanbiao Zhou1, Shi Zuo1

  • 1Department of Hepatobiliary Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, Peoples Republic of China; Department of Clinical Medicine, Guizhou Medical University, Guiyang, Guizhou, Peoples Republic of China.

Insights

Transport and Golgi organization 1 (TANGO1) promotes hepatocellular carcinoma (HCC) by enhancing proliferation and inhibiting apoptosis. TANGO1 interacts with neurturin (NRTN) to activate the PI3K/AKT/mTOR pathway, suggesting a new therapeutic target for HCC.

Area of Science:

  • Oncology
  • Molecular Biology

Background:

  • Transport and Golgi organization 1 (TANGO1), also known as MIA3, is part of the melanoma inhibitory activity (MIA) gene family.
  • The specific role of TANGO1 in hepatocellular carcinoma (HCC) pathogenesis remains largely unelucidated.

Purpose of the Study:

  • To investigate the role and underlying molecular mechanisms of TANGO1 in hepatocellular carcinoma (HCC) progression.
  • To explore the potential of the TANGO1/neurturin (NRTN) axis as a therapeutic target in HCC.

Main Methods:

  • RNA sequencing (RNA-seq) was employed to identify molecular pathways associated with TANGO1's function in HCC.
  • Endogenous co-immunoprecipitation (Co-IP) and confocal microscopy were used to confirm the interaction between TANGO1 and NRTN.
  • Functional assays assessed the impact of TANGO1 on HCC cell proliferation, apoptosis, and epithelial-mesenchymal transition (EMT).

Main Results:

  • TANGO1 was confirmed to promote HCC progression, characterized by increased proliferation, inhibited apoptosis, and enhanced EMT.
  • TANGO1 inhibition reversed these pro-tumorigenic effects in HCC cells.
  • TANGO1 was found to interact with neurturin (NRTN), and both proteins were shown to promote HCC progression via activation of the PI3K/AKT/mTOR signaling pathway.

Conclusions:

  • TANGO1 acts as an oncogene in hepatocellular carcinoma (HCC).
  • The TANGO1/NRTN axis promotes HCC by activating the PI3K/AKT/mTOR signaling pathway.
  • Targeting the TANGO1/NRTN axis presents a promising therapeutic strategy for HCC treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.5K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K